A modified acupuncture needle enables minimally invasive sampling of lymph node-derived DNA for molecular profiling, offering a robust alternative to current clinical liquid biopsy approaches. The novel platform, His@PDA@Needle, is significantly less invasive than conventional lymph node biopsy and intended to complement histopathologi...
Genetic research challenges a decades-old model on cattle pregnancy, finding embryos lacking interferon tau can establish and maintain pregnancies, resulting in healthy calves. The team used CRISPR-Cas9 gene editing to eliminate IFNT genes and generated cloned embryos, which developed normally and successfully established pregnancies.
Researchers developed an iron-modified titanium dioxide electrode that removed 92.1% of nitrobenzene within two hours, with 62.4% mineralization. The iron-modified electrode enhanced pollutant interactions and increased the effectiveness of a combined treatment process.
Researchers found that gut bacteria-derived polyamines, including putrescine and spermidine, contribute to extended lifespan in fruit flies. The study used genetically engineered E. coli to investigate the specific contribution of polyamines to host lifespan, revealing a sex-dependent effect with males living longer than females.
The book explores diverse microbial strategies for wastewater remediation, including indigenous microorganisms and genetically modified microorganisms. Advanced technologies such as biosorption and membrane bioreactors are also examined, highlighting their potential to address the growing global challenge of wastewater pollution.
A novel ex vitro transformation method utilizes Agrobacterium rhizogenes to genetically modify woody plants' roots, eliminating the need for tissue culture. This approach accelerates the development of genetically engineered trees, making it a cost-effective and scalable solution for the forestry and agricultural sectors.
A European consortium, led by Universitat Jaume I, aims to develop genetically modified citrus lines with greater resilience to climate change, pests, and diseases. The project, CitrusAld, will focus on sweet orange and mandarin, and explore biofortification to enhance nutritional properties.
Researchers developed a cost-effective method to enhance the strength and thermal stability of 3D printing resins using modified mineral acicular wollastonite. The modified resin showed better thermal stability and reduced curing shrinkage, improving dimensional accuracy of printed parts.
Researchers from Boston Children's Hospital have developed a new gene therapy approach that collects enough stem cells in a single hospital admission, improving turnaround time for genetically altering and infusing cells. The approach has shown long-term stability and safety, with patients not experiencing any adverse effects.
Researchers developed an innovative vaccine strategy that uses genetically modified viruses to protect against Chikungunya and other diseases. The new approach generates antibodies without causing disease, paving the way for a robust vaccine platform with broad protective potential.
A team of researchers successfully measured pollen dispersal from a genetically engineered switchgrass crop using ground samplers, drones, and simulations. They established a modeling methodology for future prediction, which can help improve strategies for managing pollen movement and forecasting airborne allergens.
A study reveals that gut bacteria can process chemically modified amino acids from heated foods, such as CML. This enzyme, SpeC, is a 'Swiss pocket knife' that breaks down these compounds, which are not absorbed in the small intestine and pass to the large intestine.
A new UAB trial demonstrates promising results for a novel immunotherapy in treating glioblastoma. The treatment, DeltEx DRI, has been shown to more than double progression-free survival, with median overall survival reaching up to 19.5 months.
Researchers have successfully produced genome-edited T cells that can target and destroy cancer cells using the Platinum TALEN genetic engineering technique. The technique was found to be efficient, with an average yield of 72 million 1G4-TCR cells for every 3 million T-cells.
A study by researchers from the University of Ottawa found that Calling and Non-calling western toads are genetically distinct, behaviourally different, and have ecological variations. This discovery has important implications for conservation and wildlife management in Canada.
Researchers at Nara Institute of Science and Technology developed a practical, non-genetically modified brewing yeast that produces over nine times higher intracellular ornithine levels than the original yeast. The improved yeast retained normal brewing performance, making it suitable for value-added fermentation.
The study introduces a modified deep lateral wall decompression technique that improves visual acuity, exophthalmos, and intraocular pressure with low complication rates. This approach suggests a safer option for TAO management, warranting further exploration.
A new study reveals that thiol-modified biochar can maintain long-term mercury immobilization in contaminated soils even when subjected to repeated drying and rewetting. The research found that TMB strongly reduced mercury mobility, lowered bioavailable mercury, and redistributed mercury into less available forms.
Researchers found that acid-modified and alkaline biochars helped reduce stress from saline-alkali soil, improving soil conditions and supporting alfalfa performance. Alkaline biochar promoted biomass growth, while acid-modified biochar improved soil chemistry and root defense in highly alkaline soils.
A study by Newcastle University reveals the Cheviot goats in Northumberland's College Valley are a historically significant and genetically distinct population. The research highlights the potential importance of native and feral livestock breeds as animal genetic resources for future agriculture.
Researchers from Fudan University published a study on modified sigmoid sinus wall reconstruction using bone cement, demonstrating a 96.2% overall success rate for symptom resolution. Symptoms typically resolved within four weeks, providing evidence for optimizing surgical techniques and material selection.
Researchers found that thiol-modified biochar reduces mercury mobility by up to 80% in soils exposed to dry-wet cycles. The material promotes natural weathering processes, traps mercury in stable forms, and alters the soil microbial community, creating a resilient ecosystem.
Researchers have developed chloride-modified bismuth nanosheets that accelerate the reduction of carbon dioxide to formate with near 100% efficiency. The modified nanosheets exhibit high formate Faradaic Efficiency and long-term stability, making them a promising catalyst for CO2 reduction.
Researchers have created genetically modified marmosets with a knocked-out OTOF gene, replicating key characteristics of human deafness. The animals developed normally but were deaf from birth, offering a crucial tool for developing new therapies.
Researchers observed female baboons' vaginal tract altering sperm survival based on male genetic makeup, with strongest responses to genetically similar males. The study suggests post-copulatory mate selection via vaginal immune responses and pH in the baboon species.
Researchers at University of Michigan Engineering and Michigan Medicine used protein nanoparticles to genetically modify several types of human cells, including liver cancer and immune cells. The goal is to develop a safer method for delivering gene therapies without using modified viruses.
Researchers developed a phosphorus-modified biochar that can simultaneously immobilize harmful metals and enhance soil fertility. The material showed remarkable adsorption capacity for lead and cadmium, with potential applications in soil remediation and sustainable agriculture.
Researchers genetically modified a probiotic yeast to reduce its virulence in immunocompromised patients. The modified yeast was found to be less likely to cause infection, with improved survival rates in animal models.
Researchers at Kyoto University developed mRNA therapy that successfully restored sperm production and enabled healthy offspring birth in genetically infertile male mice. The therapy targets genetic defects linked to male infertility, demonstrating a potential treatment for human infertility cases.
Researchers designed modified biochars with phosphorus and magnesium to improve compost quality by retaining nitrogen and accelerating humification. The study found that these materials reduced ammonia emissions and promoted microbial activity, resulting in higher nitrogen retention and improved soil fertility.
A novel engineered biochar has been developed to simultaneously immobilize arsenic and cadmium in contaminated water and agricultural soils. The sulfur-ferrihydrite-modified biochar achieves high adsorption capacities for both pollutants, transforming them into more stable residual fractions.
A new study reveals how plant mitochondria interact with chloroplasts to regulate oxygen levels, affecting photosynthesis and stress responses. This discovery sheds light on plant metabolism and energy management, offering potential insights into crop development and stress detection.
A recent study found that higher IL6 levels are associated with increased mortality, while genetically higher IL6R levels reduce all-cause mortality through cardiovascular mechanisms. The researchers suggest that IL6R antagonism may be a potential strategy for preventing cardiovascular disease.
Scientists have discovered how engineered biochar and microbes work together to enhance phytoremediation by improving soil conditions and stimulating beneficial microbes. The study found that modified biochar substantially increased plant growth, boosted photosynthesis, and promoted the transfer of cadmium from roots to stems and leaves.
Researchers discovered that inhibiting nerve cells in the brain, known as CRF neurons, can speed up the process of unlearning fear. This finding has implications for treating post-traumatic stress disorder and anxiety disorders, suggesting that targeting specific brain regions may provide new therapeutic options.
Researchers have genetically engineered therapeutic CAR T cells that can destroy solid tumors, overcoming a major obstacle in cancer treatment. By silencing prostaglandin E2 signalling, these new cells can recognize and attack cancer cells without suppressing their own immune function.
Researchers at VCU Massey Comprehensive Cancer Center and VCU Institute of Molecular Medicine are developing a novel therapy using engineered immune cells to target advanced prostate cancer. The therapy, which uses genetically modified natural killer cells producing the IL-24S 'Superkine', has shown promise in early-stage studies.
The study found that even with immunosuppressants, innate immunity remains activated, indicating a need for new therapies to prevent organ rejection. Researchers recommend combining therapies targeting innate immunity with advanced genetic engineering in donor pigs.
A patient with refractory synovial sarcoma was the first in Arizona to receive TECELRA, a genetically modified autologous T cell immunotherapy. The treatment showed early signs of tumor shrinkage and has been shown to benefit over 40% of patients with similar cancer types.
Researchers at Mass General Brigham developed a modified herpes simplex virus that stimulates the immune system to attack glioblastoma cells, increasing T-cell and natural killer cell responses. The virus, engineered to recognize markers found on glioblastoma cells, also increases overall survival in preclinical models.
Researchers found that a blend of non-toxic and genetically modified toxic corn can alter the shape of corn earworm moth wings, making them more aerodynamic and able to travel longer distances. This change in wing shape increases the moths' capability to fly long distances and spread resistance to the toxic corn.
A new method of gene editing allows for the efficient production of non-GMO, genome-edited plants without introducing foreign DNA. The technique uses Agrobacterium-mediated transient expression to enable genome editing in a transgene-free manner.
This pilot study evaluated the effectiveness of improved laser ablation with saline injection in treating early-stage lung adenocarcinoma. The modified system significantly expanded ablation zones, achieving a 100% complete ablation rate in six patients. The treatment was safe and effective, with no major complications reported.
A team of Chinese researchers has developed a low-cost biochar material that efficiently removes persistent metal complexes from water. The ferromanganese oxide-modified biochar can capture copper–citrate complexes, which are difficult to remove using conventional methods, achieving high removal rates and chemical stability.
A pioneering case of pig-to-human liver xenotransplantation has been successfully demonstrated, with the genetically engineered porcine liver functioning for an extended period in a human recipient. The patient survived for 171 days despite complications such as xenotransplantation-associated thrombotic microangiopathy.
Researchers have developed a modified biochar made from biogas residue that can efficiently remove ammonium nitrogen from water. The potassium-permanganate-modified biochar achieved an adsorption capacity up to four times greater than unmodified biochar, making it a promising tool for environmental remediation.
A new review from the University of Adelaide highlights inconsistencies in Australian crop regulations, affecting the coexistence of genetically modified (GM) and non-GM crops. The current regulatory framework is inadequate, leading to varying standards across different sectors, making it difficult for farmers to ensure compliance.
Researchers developed modified ilmenite oxygen carriers that improve hydrogen yields and redox reaction efficiency in chemical looping systems. The new carriers enable simultaneous hydrogen production, carbon dioxide capture, and power generation, paving the way for scalable, carbon-neutral energy systems.
Researchers at the University of Waterloo have developed a novel method using modified M13 bacteria to deliver targeted gene therapies for genetic disorders. This approach shows promise as a cost-effective alternative to current methods, which can be expensive and trigger toxic side effects.
Researchers at North Carolina State University have developed a controlled evolution technique that dramatically increases plasmid DNA (pDNA) production in E. coli bacteria. This breakthrough could significantly reduce the cost of gene therapies and expedite research, making pDNA resources more accessible.
Researchers developed a genetically modified mouse model to study osteogenesis imperfecta (OI), a rare genetic bone disorder. The study found that the Sp7 R342C mutation affects bone mineral density, trabecular bone volume fraction, and cortical porosity, leading to impaired bone remodeling.
Researchers at Stanford Medicine developed a way to replace more than half of the most severely affected brain cells with non-genetically matched precursor cells in mice. The approach helped animals live longer and reduced behavioral symptoms of the disease, offering hope for families of children with these rare diseases.
A modified version of the DASH diet has been shown to lower glucose levels and improve blood glucose control in adults with type 2 diabetes. The DASH4D diet, which is similar to the original DASH diet but lower in carbohydrates and higher in unsaturated fats, helped participants with type 2 diabetes control their glucose levels.
Researchers developed a CRISPR-based gene-editing system that changes a single molecule within mosquitoes, halting malaria-parasite transmission. The new system is designed to genetically spread the malaria resistance trait until entire populations of the insects no longer transfer the disease-causing parasites.
A team of researchers at Memorial Sloan Kettering Cancer Center has made a groundbreaking discovery about why genetically engineered immune cells sometimes fail to fully destroy tumors. They found that FAS ligand, produced by the immune cells themselves, causes self-destruction and reduces therapy's effectiveness.
A recent study found that behavioral flexibility is related to foraging breadth, not social or habitat use behaviors, in great-tailed grackles rapidly expanding their geographic range. The researchers discovered that flexible individuals switched between different food types more often in the wild.
A genetically engineered herpes simplex virus, RP1, shows promise in treating advanced melanoma when combined with immunotherapy. In a phase 1-2 clinical trial, one-third of patients experienced significant tumor shrinkage or disappearance, offering hope to those with untreatable cancer.
Researchers have developed a novel method to generate rats with ES cell traits using blastocyst complementation. This approach eliminates the need for fluorescent labeling and reduces costs compared to conventional techniques.
A study published in Neurobiology of Disease found that melanin degradation is impaired in genetically engineered mice lacking the SLC26A4 gene, leading to chronic inflammation and macrophage activation. The researchers propose a novel pathological cascade where melanin accumulation exacerbates hearing loss in pigmented individuals.
Researchers have deciphered a key mechanism for RNA therapeutics, explaining why certain modified RNAs evade the innate immune response. Pseudouridine modifications can avoid detection by pattern recognition receptors, such as TLR7 and TLR8, through impaired endolysosomal processing.